Dihalroergocristine

Chemical name

(5'альфа,10альфа)-9,10-Диг��дро-12'-гидрокси-2'-(1-ме��илэтил)-5'-(фенилметил) эрготаман-3'6'18-трион

Gross

C35-H41-N5-O5

Characteristics

Digidrirovanny produce LPV. White or white with serovatam white powder.

Of drugs

The drugs-alfa-adrainoliticescoe, skin. Provides centrifugal force альфа-адреноблокирую��ее Effects prevents adrenergicski acute cerebrovascular has gipotenzivny effect reduces variation, round. Is serotoninoliticaskie weak, and protivosvertawate sedating properties.

Indications

Violations of cerebral circulation due to arterial hypertension early stages of atherosclerosis cerebrovascular diseases, the effects of brain injury; Migraine, human peripheral blood circulation, incl. Reynaud disease; to improve cerebral circulation in older people.

Pregnancy and lactation

Contraindicated in pregnancy.

Contraindications

Hypersensitivity expressed arteriosclerosis, heavy to liver and / or kidney problems, heart failure, aetiology, arterial gipotenzia, pregnancy, child.

Side-Effects

Nausea, vomiting.

Patient interaction

Potenziruet the gipotenziveh funds proximity anti weakens - альфа-адреномиметико��.

Precautions

If necessary, the use of patients with reduced variation and AD requires caution.

Dosing and Administration

Inside, the food on 0.25 - 0.5 mg 2-3 times a day, if necessary and good endurance dose increase to 0.75-1 mg three times a day. Optimal dose picked individually. Course of two weeks to 1-2 months.

Directory → Wegetotropona funds → Adrainoliticaskie funds → Альфа-адреноблокатор�� → Dihalroergocristine